Combination Chemotherapy in Treating Patients With Recurrent or Refractory Leukemia or Lymphoma

NCT00047021 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

3

Enrollment

OTHER

Sponsor class

Conditions

Leukemia
Lymphoma

Interventions

BIOLOGICAL: sargramostim
DRUG: cytarabine
DRUG: mitoxantrone hydrochloride

Sponsor

Case Comprehensive Cancer Center

Collaborators

[object Object]